{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:18:41Z","timestamp":1787948321844,"version":"build-2784847793"},"reference-count":103,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jaad.2008.11.906","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T04:17:31Z","timestamp":1240373851000},"page":"824-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":264,"title":["Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference"],"prefix":"10.1016","volume":"60","author":[{"given":"Robert E.","family":"Kalb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Strober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2008.11.906_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2133.1977.tb15068.x","article-title":"Cutaneous sarcoidosis treated with methotrexate","volume":"97","author":"Veien","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(68)90649-1","article-title":"Treatment of dermatomyositis with methotrexate","volume":"2","author":"Malaviya","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2008.11.906_bib3","first-page":"326","article-title":"Treatment of pyoderma gangrenosum with methotrexate","volume":"57","author":"Teitel","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2008.11.906_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis: consensus conference","volume":"38","author":"Roenigk","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update","volume":"46","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","article-title":"Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis","volume":"349","author":"Heydendael","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.11.906_bib7","first-page":"116","article-title":"Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial","volume":"158","author":"Flytstrom","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","article-title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","volume":"158","author":"Saurat","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1529-8019.2007.00135.x","article-title":"Methotrexate in dermatology","volume":"20","author":"Bangert","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jaad.2008.11.906_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2710.2007.00834.x","article-title":"Methods to enhance the safety of methotrexate prescribing","volume":"32","author":"Goldsmith","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2133.2007.08426.x","article-title":"Methotrexate: prescribing and monitoring practices among the consultant membership of the British Association of Dermatologists","volume":"158","author":"Collin","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.23144","article-title":"Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with rheumatoid arthritis","volume":"58","author":"Braun","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.1780390214","article-title":"Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis","volume":"39","author":"Gutierrez-Ure\u00f1a","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaad.2007.11.011","article-title":"The effect of weight on the efficacy of biologic therapy in patients with psoriasis","volume":"58","author":"Clark","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaad.2005.06.036","article-title":"Folate supplementation during methotrexate therapy for patients with psoriasis","volume":"53","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1365-2133.2006.07289.x","article-title":"Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial","volume":"154","author":"Salim","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2133.2007.08005.x","article-title":"Folate with methotrexate: big benefit, questionable cost","volume":"157","author":"Brownell","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2133.2005.06605.x","article-title":"Noninvasive monitoring for methotrexate hepatotoxicity","volume":"152","author":"MacDonald","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib21","first-page":"727","article-title":"Absence of pulmonary fibrosis in patients with psoriatic arthritis treated with low dose weekly methotrexate","volume":"19","author":"Belzunegui","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/art.20278","article-title":"Toward a better understanding of methotrexate","volume":"50","author":"Kremer","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.11.906_bib23","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jaad.2005.09.015","article-title":"Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis","volume":"57","author":"Maruani","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jaad.2006.09.011","article-title":"Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin","volume":"56","author":"Clarke","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/rheumatology\/40.3.341","article-title":"Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis","volume":"40","author":"Binymin","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2008.11.906_bib26","first-page":"888","article-title":"Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate","volume":"25","author":"Gwak","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","article-title":"Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate","volume":"59","author":"Buchbinder","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2008.11.906_bib29","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/08860220500461328","article-title":"Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature","volume":"28","author":"Yang","year":"2006","journal-title":"Renal Failure"},{"key":"10.1016\/j.jaad.2008.11.906_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0190-9622(98)70387-1","article-title":"Thrombocytopenia after a single test dose of methotrexate","volume":"39","author":"Jih","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib32","first-page":"648","article-title":"Pancytopenia after single intradermal infiltration of methotrexate","volume":"4","author":"Cohen","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10067-006-0301-7","article-title":"Low-dose methotrexate induced pancytopenia","volume":"26","author":"Singh","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0049-0172(85)90029-0","article-title":"Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis","volume":"15","author":"McKinnon","year":"1985","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2006.03047.x","article-title":"Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent","volume":"24","author":"Berends","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0190-9622(00)90237-8","article-title":"Liver biopsies and methotrexate: a time for reconsideration?","volume":"42","author":"Zachariae","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of nonalcoholic steatohepatitis in methotrexate induced liver injury","volume":"16","author":"Langman","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000088497","article-title":"Have methotrexate-induced liver fibrosis and cirrhosis become rare?","volume":"211","author":"Zachariae","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2008.11.906_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaad.2006.12.005","article-title":"Reconsidering liver biopsies during methotrexate therapy","volume":"56","author":"Henning","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib42","first-page":"1727","article-title":"Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis","volume":"31","author":"Kent","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib43","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/art.1780380814","article-title":"Usefulness of the American College of Rheumatology Recommendations for Liver Biopsy in Methotrexate Treated Rheumatoid Arthritis Patients","volume":"38","author":"Erickson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","article-title":"Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified?","volume":"19","author":"Aithal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00128071-200506060-00003","article-title":"Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?","volume":"6","author":"Thomas","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2133.2005.06422.x","article-title":"Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis","volume":"152","author":"Chalmers","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.2005.06459.x","article-title":"Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen","volume":"152","author":"Maurice","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/pgmj.2005.041533","article-title":"Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis","volume":"82","author":"Khan","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaad.2008.11.906_bib49","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1478-3231.2007.01592.x","article-title":"Percutaneous liver biopsy in clinical practice","volume":"27","author":"Al Knawy","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jaad.2008.11.906_bib50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.1780370304","article-title":"Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology","volume":"37","author":"Kremer","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib51","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archderm.143.12.1515","article-title":"Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens","volume":"143","author":"Berends","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2230.2006.02153.x","article-title":"Methotrexate and ciclosporin combination for the treatment of severe psoriasis","volume":"31","author":"Aydin","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2133.1999.02976.x","article-title":"Combination treatment with methotrexate and ciclosporin for severe recalcitrant psoriasis","volume":"141","author":"Clark","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib54","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaad.2006.01.004","article-title":"Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study","volume":"54","author":"Asawanonda","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0190-9622(82)70157-4","article-title":"Combined methotrexate-ultraviolet B therapy in the treatment of psoriasis","volume":"7","author":"Paul","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0190-9622(82)70005-2","article-title":"Combined methotrexate-PUVA therapy in the treatment of psoriasis","volume":"6","author":"Morison","year":"1982","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2008.11.906_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sder.2005.01.002","article-title":"Combining traditional agents and biologics for the treatment of psoriasis","volume":"24","author":"Cather","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2008.11.906_bib58","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1396-0296.2004.04046.x","article-title":"Biologics in combination with nonbiologics: efficacy and safety","volume":"17","author":"Stebbins","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib59","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-4632.2005.02626.x","article-title":"Etanercept and psoriasis, from clinical trials to real life","volume":"44","author":"Jacob","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib60","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-4632.2008.03419.x","article-title":"Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis","volume":"47","author":"Yamauchi","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/09546630701759579","article-title":"Concurrent use of methotrexate and acitretin revisited","volume":"19","author":"Lowenthal","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2008.11.906_bib62","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/01485010490250533","article-title":"Effect of chronic low dose methotrexate on cellular proliferation during spermatogenesis in rats","volume":"50","author":"Saxena","year":"2004","journal-title":"Arch Androl"},{"key":"10.1016\/j.jaad.2008.11.906_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199107183250301","article-title":"Congenital abnormalities in children of patients who received chemotherapy for cancer in childhood and adolescence","volume":"325","author":"Green","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.11.906_bib65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0190-9622(93)70270-4","article-title":"Methotrexate and reproduction in men: case report and recommendations","volume":"29","author":"Morris","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archderm.1980.01640260091025","article-title":"Psoriasis, methotrexate and oligospermia","volume":"116","author":"Sussman","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib67","first-page":"577","article-title":"Effect of methotrexate on male fertility","volume":"49","author":"French","year":"2003","journal-title":"Can Family Phys"},{"key":"10.1016\/j.jaad.2008.11.906_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/01485017908985067","article-title":"Methotrexate and fertility in men","volume":"3","author":"El-Beheiry","year":"1979","journal-title":"Arch Androl"},{"key":"10.1016\/j.jaad.2008.11.906_bib69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bmj.327.7416.669","article-title":"Male subfertility","volume":"327","author":"Hirsh","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2008.11.906_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1610-0387.2007.06169.x","article-title":"Systemic dermatological treatment with relevance for male fertility","volume":"5","author":"Grunewald","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2008.11.906_bib71","first-page":"A314","article-title":"Sperm chromosome studies in patients taking low dose methotrexate","volume":"51","author":"Estop","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2008.11.906_bib72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/qjmed\/92.10.551","article-title":"The effects of methotrexate on pregnancy, fertility and lactation","volume":"92","author":"Lloyd","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.jaad.2008.11.906_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830360404","article-title":"Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children","volume":"36","author":"Aviles","year":"1991","journal-title":"Am J Haematol"},{"key":"10.1016\/j.jaad.2008.11.906_bib74","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/03009749950155337","article-title":"Perinatal outcome in pregnancies of women with connective tissue disease and inflammatory rheumatic disease in Norway","volume":"28","author":"Skomsvoll","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib75","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.5694\/j.1326-5377.1971.tb92712.x","article-title":"Methotrexate-induced congenital malformations","volume":"2","author":"Powell","year":"1971","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2008.11.906_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9343(90)90522-F","article-title":"Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease","volume":"88","author":"Kozlowski","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2008.11.906_bib77","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/tera.1420470605","article-title":"Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy","volume":"47","author":"Feldcamp","year":"1993","journal-title":"Teratology"},{"key":"10.1016\/j.jaad.2008.11.906_bib78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/tera.1420490202","article-title":"Methotrexate exposure prior to and during pregnancy","volume":"49","author":"Donnenfeld","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.jaad.2008.11.906_bib79","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.1780400527","article-title":"Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother","volume":"40","author":"Buckley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-9926(199907)60:1<10::AID-TERA5>3.0.CO;2-H","article-title":"Developmental delay in fetal aminopterin\/methotrexate syndrome","volume":"60","author":"Del Campo","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.jaad.2008.11.906_bib81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pd.334","article-title":"In utero first trimester exposure to low-dose methotrexate with increased fetal nuchal translucency and associated malformations","volume":"22","author":"Kr\u00e4henmann","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jaad.2008.11.906_bib82","first-page":"599","article-title":"Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester","volume":"99","author":"Nguyen","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2008.11.906_bib83","first-page":"2360","article-title":"Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study","volume":"31","author":"Lewden","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib84","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/bdra.20116","article-title":"A de novo, apparently balanced reciprocal translocation in a child with developmental delay whose mother was being treated with low-dose methotrexate at the time of conception","volume":"73","author":"Delatycki","year":"2005","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.jaad.2008.11.906_bib85","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaad.2004.07.043","article-title":"Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature","volume":"52","author":"Dadlani","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.11.906_bib86","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaad.2005.10.056","article-title":"Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis","volume":"54","author":"Kress","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib87","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ncprheum0562","article-title":"Combination therapy for rheumatoid arthritis: methotrexate and Sulfasalazine together or with other DMARDs","volume":"3","author":"Dale","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib88","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.20375","article-title":"Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis","volume":"50","author":"Jansen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.11.906_bib89","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00278469","article-title":"The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis","volume":"42","author":"Tracy","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2008.11.906_bib90","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0091270005280100","article-title":"Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis","volume":"45","author":"Vakily","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2008.11.906_bib91","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/jpet.107.121491","article-title":"Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices","volume":"322","author":"Nozaki","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib92","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2125.1994.tb05713.x","article-title":"Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis","volume":"37","author":"Tracy","year":"1994","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.jaad.2008.11.906_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/rheumatology\/35.suppl_1.13","article-title":"A review of the clinical pharmacokinetics of meloxicam","volume":"35","author":"T\u00fcrck","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib94","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1345\/aph.1E044","article-title":"Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients","volume":"38","author":"Hartmann","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2008.11.906_bib95","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1177\/00912700122012616","article-title":"Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients","volume":"41","author":"Schwartz","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2008.11.906_bib96","first-page":"2539","article-title":"Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis","volume":"26","author":"Karim","year":"1999","journal-title":"J Rheumatol"},{"issue":"6 Suppl. 18","key":"10.1016\/j.jaad.2008.11.906_bib97","first-page":"S66","article-title":"Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis","volume":"17","author":"Mroczkowski","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.11.906_bib98","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2003.016014","article-title":"990145 Study Group. A multicentre, double blind, randomized, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate","volume":"63","author":"Cohen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2008.11.906_bib99","first-page":"1913","article-title":"Effect of penicillin on the renal tubular secretion of methotrexate in the monkey","volume":"44","author":"Williams","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2008.11.906_bib100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002800050840","article-title":"Influence of piperacillin on the pharmacokinetics of methotrexate and 7-hydroxymethotrexate","volume":"42","author":"Najjar","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaad.2008.11.906_bib101","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0022-5347(25)00387-8","article-title":"Drug inhibition of penicillin tubular secretion: concordance between in vitro and clinical findings","volume":"240","author":"Nierenberg","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2008.11.906_bib102","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02897260","article-title":"Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits","volume":"26","author":"Iven","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaad.2008.11.906_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00043426-200205000-00021","article-title":"Interaction between methotrexate and ciprofloxacin","volume":"24","author":"Dalle","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaad.2008.11.906_bib104","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2007.076406","article-title":"Methotrexate combined with isoniazid therapy for latent tuberculosis is well tolerated in rheumatoid arthritis patients: experience from an urban arthritis clinic","volume":"67","author":"Mor","year":"2008","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208024821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208024821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:12:54Z","timestamp":1759270374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208024821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":103,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0190962208024821"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2008.11.906","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2008.11.906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}